US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

652.82

+24.563.91%

Number of Gainers:4

Number of Losers:- -

Number of Flat:- -

PE:- -

High:657.91

Open:628.06

Low:620.57

Close:628.26

Volume:24.82M

Turnover:461.97M

Market Cap:20.73B

Float Cap:16.08B

Loading ...

Tempus AI Founder Supports Anthropic CEO’s Call for Slowdown - Bloomberg News

THOMSON REUTERS

Tempus AI CEO Sees Healthcare Sector as Biggest AI Beneficiary

Tempus AI to build multimodal whole-genome dataset for AI-driven healthcare

Tempus AI Launches Effort to Build 100,000 Whole-Genome Dataset Linked to Clinical Outcomes

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

THOMSON REUTERS

Tempus AI, - General Availability of Dataset Planned for Mid-2027

THOMSON REUTERS

Recursion Pharma CEO Najat Khan Sells 22,408 Shares for $78,822

Cathie Wood’s ARK Investment buys 271K shares of Beam Therapeutics today

Tempus AI awarded up to $9.5M from ARPA-H for autonomous AI in cardiology

Tempus AI Wins up to $9.5 Million ARPA-H Advocate Award for Autonomous Heart Failure Agent

Tempus Secures up to $9.5 Million in Arpa-H Advocate Funding to Deploy First Autonomous AI in Cardiology

THOMSON REUTERS

Tempus AI Initiated at Neutral by UBS

UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target

MT Newswires Live

JonesTrading Remains a Buy on Beam Therapeutics (BEAM)

Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)

Shares of Beam Therapeutics Retreat After Updated Trial Data Disappoints

Beam Therapeutics falls -12.7%

Tempus AI Price Target Announced at $67.00/Share by Roth Capital

CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Rothschild & Co Redburn Initiates Tempus AI at Neutral With $67 Price Target

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/stock/BK4611/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":652.8213,"timestamp":1789415999999,"preClose":628.2648,"halted":0,"volume":24818128,"delay":0,"changeRate":0.039086,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":24.556519,"latestTime":"09-14 16:00:00 EDT","open":628.0634,"high":657.9077,"low":620.5683,"amount":461974056.936305,"amplitude":0.059433,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.739347,"peRate":-15.089385,"turnoverRate":0.030189,"increases":4,"decrements":0,"flats":0,"marketCap":20731097216,"floatMarketCap":16078834560},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":657.9077,"amplitude":0.059433,"preClose":628.2648,"low":620.5683,"pbRate":"4.739347","latestPrice":652.8213,"volume":24818128,"delay":0,"open":628.0634,"prevYearClose":658.3995,"prevWeekClose":628.2648,"prevMonthClose":691.9381,"prevQuarterClose":681.0329,"fiveDayClose":700.621,"twentyDayClose":611.922,"sixtyDayClose":617.4418,"secType":"PLATE","market":"US","turnoverRate":0.030189,"peRate":-15.089385,"marketCap":20731097216,"floatMarketCap":16078834560,"timestamp":1789415999999,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":4,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667695684","title":"Tempus AI Founder Supports Anthropic CEO’s Call for Slowdown - Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695684","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695684?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:31","pubTimestamp":1789417870,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4560I2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","HEAL","ARKG","TEMT","BK4611","BK4613","LU1861558580.USD","TEM","LU1861559042.SGD","TEMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667203693","title":"Tempus AI CEO Sees Healthcare Sector as Biggest AI Beneficiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2667203693","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667203693?lang=en_us&edition=fundamental","pubTime":"2026-09-15 03:58","pubTimestamp":1789415880,"startTime":"0","endTime":"0","summary":"1557 ET - Health tech is most likely to be the biggest beneficiary from AI, Tempus AI Chief Executive Eric Lefkofsky says on CNBC. AI models can make sense of large amounts of unstructured disparate data, which is the form most healthcare data takes, Lefkofsky says. Tempus specializes in using AI and data to improve the efficacy of diagnostics. Lefkofsky sees AI as opening the way to personalize treatments such as vaccines based on individuals' needs and genetic makeups.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","LU1861558580.USD","TEMC","TEM","HEAL","BK4613","ARKG","BK4121","LU1861559042.SGD","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666452289","title":"Tempus AI to build multimodal whole-genome dataset for AI-driven healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2666452289","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666452289?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:35","pubTimestamp":1789130126,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced an initiative to build a research platform containing 100,000 whole genomes linked to longitudinal clinical information o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-to-build-multimodal-whole-genome-dataset-for-ai-driven-healthcare-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-to-build-multimodal-whole-genome-dataset-for-ai-driven-healthcare-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEM","LU1861558580.USD","BK4121","LU1861559042.SGD","TEMC","TEMT","HEAL","BK4613","ARKG","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666524480","title":"Tempus AI Launches Effort to Build 100,000 Whole-Genome Dataset Linked to Clinical Outcomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2666524480","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666524480?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:30","pubTimestamp":1789129839,"startTime":"0","endTime":"0","summary":"Tempus AI launches effort to build 100,000 whole-genome dataset linked to clinical outcomesTempus AI launched an initiative to build a research platform of 100,000 disease-specific whole-genome sequen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL24lzy4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","BK4121","LU1861559042.SGD","TEMT","LU1861558580.USD","TEMC","BK4613","TEM","ARKG","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666524109","title":"Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666524109","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666524109?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:30","pubTimestamp":1789129800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nTUA6Z97LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEMC","TEM","HEAL","BK4121","BK4613","ARKG","LU1861558580.USD","TEMT","LU1861559042.SGD","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666268524","title":"Tempus AI, - General Availability of Dataset Planned for Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2666268524","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666268524?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:30","pubTimestamp":1789129800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nTUA6Z97LZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEMT","BK4613","LU1861558580.USD","BK4611","LU1861559042.SGD","TEM","HEAL","ARKG","BK4121","TEMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666851602","title":"Recursion Pharma CEO Najat Khan Sells 22,408 Shares for $78,822","url":"https://stock-news.laohu8.com/highlight/detail?id=2666851602","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666851602?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:56","pubTimestamp":1789077394,"startTime":"0","endTime":"0","summary":"Recursion Pharma CEO Najat Khan sells 22,408 shares for $78,822Recursion Pharmaceuticals CEO and President Najat Khan sold 22,408 Class A common shares on Sep. 8, 2026.Sale priced at USD 3.52 per shar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL810t6S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Recursion Pharma CEO Najat Khan Sells 22,408 Shares for $78,822","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4139","BK4539","BK4611","BK4609","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666555446","title":"Cathie Wood’s ARK Investment buys 271K shares of Beam Therapeutics today","url":"https://stock-news.laohu8.com/highlight/detail?id=2666555446","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666555446?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:10","pubTimestamp":1788999015,"startTime":"0","endTime":"0","summary":"20:05 EDT Cathie Wood’s ARK Investment buys 271K shares of Beam Therapeutics (BEAM) today Published first on TheFly – the ultimate source for real-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-271k-shares-of-beam-therapeutics-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-271k-shares-of-beam-therapeutics-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","ARKF","BK4556","SARK","BK4611","LU1861558580.USD","ARKQ","ARKW","ARKX","BK4588","BK4535","ARKK","BK4139","BK4007","BK4544","BK4505","LENZ","BK4585","BEAM","ARKG","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530872","title":"Tempus AI awarded up to $9.5M from ARPA-H for autonomous AI in cardiology","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530872","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530872?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:05","pubTimestamp":1788984341,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced that it has been selected by the Advanced Research Projects Agency for Health, an agency within the U.S. Department of He...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-awarded-up-to-9-5m-from-arpa-h-for-autonomous-ai-in-cardiology-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-awarded-up-to-9-5m-from-arpa-h-for-autonomous-ai-in-cardiology-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEMC","TEM","HEAL","BK4121","BK4613","ARKG","LU1861558580.USD","TEMT","LU1861559042.SGD","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371155","title":"Tempus AI Wins up to $9.5 Million ARPA-H Advocate Award for Autonomous Heart Failure Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371155","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371155?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:01","pubTimestamp":1788984085,"startTime":"0","endTime":"0","summary":"Tempus AI wins up to $9.5 million ARPA-H ADVOCATE award for autonomous heart failure agentTempus AI won up to USD 9.5 million from the US Department of Health and Human Services’ ARPA-H ADVOCATE progr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL94GQX6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","ARKG","LU1861559042.SGD","TEMC","TEM","HEAL","TEMT","BK4121","BK4613","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666164537","title":"Tempus Secures up to $9.5 Million in Arpa-H Advocate Funding to Deploy First Autonomous AI in Cardiology","url":"https://stock-news.laohu8.com/highlight/detail?id=2666164537","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666164537?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:01","pubTimestamp":1788984074,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN4510GH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4611","LU1861559042.SGD","TEM","HEAL","TEMC","TEMT","BK4613","LU1861558580.USD","BK4121","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666536365","title":"Tempus AI Initiated at Neutral by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2666536365","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666536365?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:35","pubTimestamp":1788960900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4121","ARKG","TEM","LU1861558580.USD","HEAL","TEMC","TEMT","LU1861559042.SGD","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666382905","title":"UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2666382905","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666382905?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:17","pubTimestamp":1788956270,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has an average rating of overweight and mean price target of $66.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARKG","BK4613","HEAL","LU1861558580.USD","TEMT","BK4611","LU1861559042.SGD","BK4121","TEMC","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666747538","title":"JonesTrading Remains a Buy on Beam Therapeutics (BEAM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666747538","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666747538?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:15","pubTimestamp":1788956156,"startTime":"0","endTime":"0","summary":"In a report released today, Boris Peaker from JonesTrading reiterated a Buy rating on Beam Therapeutics, with a price target of $35.00. According t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jonestrading-remains-a-buy-on-beam-therapeutics-beam-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jonestrading-remains-a-buy-on-beam-therapeutics-beam-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4535","BEAM","BK4611","LU1861558580.USD","LU1861559042.SGD","BK4588","BK4505","BK4139","BK4556"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666630973","title":"Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666630973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666630973?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:30","pubTimestamp":1788921013,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-amgen-amgn-beam-therapeutics-beam-and-royalty-pharma-rprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-amgen-amgn-beam-therapeutics-beam-and-royalty-pharma-rprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BEAM","IE0009355771.USD","BK4566","LABU","BK4533","IE0002141913.USD","IE00BFTCPJ56.SGD","IBBQ","LU0029874061.USD","LU2112291526.USD","IBB","XLV","BK4535","LU0320765992.SGD","LU1023059063.AUD","BBH","RPRX","BK4534","BIB","LU1861559042.SGD","IE00BJJMRZ35.SGD","PBE","LU0109394709.USD","AMGN","BK4007","BK4505","LU1057294990.SGD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU1983299246.USD","HCSG","BK4137","SG9999001440.SGD","LU2242652126.USD","BK4139","BK4588","BK4599","LU0868494617.USD","LU2242646821.SGD","TBXU","BK4611","LU2468319806.SGD","XBI","LU1861558580.USD","IHE","IE00BJT1NW94.SGD","IE00B2B36J28.USD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372629","title":"Shares of Beam Therapeutics Retreat After Updated Trial Data Disappoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372629","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372629?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:24","pubTimestamp":1788895440,"startTime":"0","endTime":"0","summary":"Beam Therapeutics shares were down after the company shared updated data for its trial of a treatment for the genetic condition alpha-1 antitrypsin deficiency.Shares declined 9% to $26.88 on Tuesday. The stock is roughly flat this year.In a Phase 1/2 trial evaluating BEAM-302 for AATD, the treatment was well tolerated with an acceptable safety profile, the company said.The updated results were not worse than previous data, but were not numerically better, either, Evercore ISI analysts led by Cory Kasimov said.At the 12-month mark, total alpha-1 antitrypsin in treated patients came down to 13.5 uM  to 14.4 uM, compared with 16.1 uM at the nine-month mark. The treatment is supposed to increase alpha-1 antitrypsin, a protein made by the liver.About 41% of patients experienced adverse events, with the most common being mild-to-moderate infusion-related reactions.Based on the feedback from the Food and Drug Administration, Beam plans to pursue an accelerated approval pathway for the treatme","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4505","LENZ","LU1861558580.USD","BEAM","BK4139","LU1861559042.SGD","BK4611","BK4007","BK4539","BK4585","BK4556","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376646","title":"Beam Therapeutics falls -12.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376646","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376646?lang=en_us&edition=fundamental","pubTime":"2026-09-08 22:06","pubTimestamp":1788876363,"startTime":"0","endTime":"0","summary":"Beam Therapeutics (BEAM) is down -12.7%, or -$3.78 to $25.88. Published first on TheFly – the ultimate source for real-time, market-moving breaking...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beam-therapeutics-falls-12-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beam-therapeutics-falls-12-7-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4611","BK4556","BK4585","BK4539","BK4139","BEAM","LENZ","LU1861558580.USD","BK4588","LU1861559042.SGD","BK4007","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378451","title":"Tempus AI Price Target Announced at $67.00/Share by Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378451","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378451?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:34","pubTimestamp":1788870840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TEM/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4613","TEM","TEMC","LU1861559042.SGD","BK4121","TEMT","ARKG","HEAL","BK4611","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665378198","title":"CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665378198","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665378198?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:30","pubTimestamp":1788870600,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland and BOSTON, Sept.  08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the Morgan Stanley 24th A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357662/0/en/crispr-therapeutics-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","LU0128526141.USD","BK4588","BK4137","LU1861558580.USD","LABU","XBI","BK4581","LU0029874061.USD","LU1861559042.SGD","SYNB","BK4585","BK4611","HCSG","XLV","ARKG","CRSP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665321422","title":"Rothschild & Co Redburn Initiates Tempus AI at Neutral With $67 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2665321422","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665321422?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:12","pubTimestamp":1788862369,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has an average rating of overweight and mean price target of $66.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HEAL","BK4121","LU1861559042.SGD","TEMT","LU1861558580.USD","TEMC","BK4613","TEM","ARKG","BK4611"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}]}}